GSK to acquire vaccine technology company Okairos
UK-based pharmaceutical major GlaxoSmithKline (GSK) has purchased Switzerland-based vaccine company Okairos in a deal worth €250m.
ByUK-based pharmaceutical major GlaxoSmithKline (GSK) has purchased Switzerland-based vaccine company Okairos in a deal worth €250m.
By LiamSanofi has won US Food and Drug Administration approval for its multiple sclerosis medication Aubagio.
By LiamA vaccine for dengue fever developed by Sanofi has shown the potential to protect against three of the four…
By LiamNovartis has taken to the stand in India's Supreme Court, arguing for patent protection for its cancer drug Glivec…
By LiamThe UK Department of Health has issued a warning to the nation's National Health Service (NHS) following the death…
By LiamAstraZeneca has decided to discontinue the development of obesity drug AZD2820 after a patient given the drug as part…
By LiamUS-based pharmaceutical company Jazz Pharmaceuticals has announced a deal to sell its women's health business to Meda for $95m…
By LiamA drug advisory panel has recommended that the US Food and Drug Administration approve Novartis' inhaled cystic fibrosis medication…
By LiamThe US Food and Drug Administration has approved Pfizer’s Bosulif, used to treat a rare type of leukaemia usually…
By LiamThank you for subscribing to Pharmaceutical Technology